EXTRACORPOREAL CIRCUIT W/DURAFLO II HEPARIN TREATM— 510(k) K932208

Substantially Equivalent

Baxter Healthcare Corp

FDA 510(k) clearance K932208 for EXTRACORPOREAL CIRCUIT W/DURAFLO II HEPARIN TREATM, Substantially Equivalent on 1994-08-09. Applicant: Baxter Healthcare Corp.

Clearance details

Applicant: Baxter Healthcare Corp
Product code: Code DWF
Advisory panel: Cardiovascular
Date received: 1993-05-06
Decision date: 1994-08-09
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Irvine, CA, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code DWF

product code DWF

Death: 106
Injury: 386
Malfunction: 2,323
Total: 2,815

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.